SMN2 and amyotrophic lateral sclerosis: Multiple studies suggest that deletion of SMN2 leads to increased risk of the sporadic forms of amyotrophic lateral sclerosis (ALS) (Veldink et al., 2001, 2005; Kim et al., 2010; Corcia et al., 2012; Lee et al., 2012).